RecruitingN/Aketamine

Ketamine Treatment Plans for Chronic Conditions

Sponsored by RIVER Foundation

NCT ID
NCT06038409
Target Enrollment
500 participants
Start Date
2023-01-01
Est. Completion
2029-06-01

About This Study

A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.

Conditions Studied

Chronic PainDepressive DisorderAnxiety DisordersChronic Disease

Interventions

  • •Ketamine

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

Must have an identifiable chronic condition.

Exclusion Criteria:

Healthy population

Study Locations (1)

RIVER Telehealth
Helena, Montana, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Ed Lesofski
CONTACT
406-465-9504ed@riverofchange.org
James Taggart, MD
CONTACT
415-713-6654jrtaggartmd@aol.com
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Ketamine Treatment Plans for Chronic Conditions | Huxley